A total of 10 genes that were disrupted or within breakpoint‐associated TAD structures were classified as known (FHIT, FLCN, NCOA4, and RET) or candidate cancer genes (LLGL1, LRIG1, LYRM9, RASGEF1A, ST3GAL6, and TMEM199; Table 6). This evidence concerns the gene LYRM9 and cancer.